Back
Day Range
$5.28
$5.51
52-Week Range
$3.21
$8.40
Volume
3,830,071
50D / 200D Avg
$6.82
/
$5.67
Prev Close
$5.31
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -21.1 | 0.4 |
| P/B | 7.8 | 2.9 |
| ROE % | -36.2 | 3.8 |
| Net Margin % | -15.1 | 3.9 |
| Rev Growth 5Y % | 152.0 | 10.0 |
| D/E | 1.3 | 0.2 |
Key Takeaways
Revenue grew 152.02% annually over 5 years — strong growth
Negative free cash flow of -43.98M
Revenue growth is decelerating — 1Y growth trails 5Y average by 129.93%
Capital efficient — spends only 0.37% of revenue on capex
Growth
Revenue Growth (5Y)
152.02%
Revenue (1Y)22.09%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-36.21%
ROIC-8.12%
Net Margin-15.12%
Op. Margin-10.06%
Safety
Debt / Equity
1.27
Current Ratio4.31
Interest Coverage-1.44
Valuation
P/E Ratio
-21.14
P/B Ratio7.80
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 22.09% | Revenue Growth (3Y) | 80.91% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 152.02% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 407.32M | Net Income (TTM) | -61.60M |
| ROE | -36.21% | ROA | -12.28% |
| Gross Margin | 90.29% | Operating Margin | -10.06% |
| Net Margin | -15.12% | Free Cash Flow (TTM) | -43.98M |
| ROIC | -8.12% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.27 | Current Ratio | 4.31 |
| Interest Coverage | -1.44 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -21.14 | P/B Ratio | 7.80 |
| P/S Ratio | 3.20 | PEG Ratio | -0.43 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.30B | Enterprise Value | 1.45B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 407.32M | 333.62M | 124.46M | 52.16M | 10.10M |
| Net Income | -61.60M | -39.14M | -66.07M | -67.21M | -158.17M |
| EPS (Diluted) | -0.26 | -0.17 | -0.30 | -0.42 | -1.52 |
| Gross Profit | 367.78M | 283.06M | 106.66M | 48.04M | 9.10M |
| Operating Income | -40.98M | -27.95M | -63.28M | -63.76M | -154.35M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 501.60M | 435.75M | 297.58M | 190.07M | 149.91M |
| Total Liabilities | 334.66M | 262.47M | 130.76M | 91.74M | 67.30M |
| Shareholders' Equity | 166.95M | 173.29M | 166.82M | 98.33M | 82.62M |
| Total Debt | 211.60M | 153.44M | 55.98M | 36.46M | 45.50M |
| Cash & Equivalents | 68.00M | 64.93M | 21.47M | 96.14M | 72.43M |
| Current Assets | 382.32M | 356.45M | 246.11M | 153.60M | 133.65M |
| Current Liabilities | 88.61M | 77.83M | 50.39M | 65.60M | 52.82M |